Absci Corporation, a data-first generative AI drug creation company, announced the initiation of IND-enabling studies for ABS-101, a potential best-in-class anti-TL1A antibody designed using...
ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty biologics, announced the successful initial use of its Artificial...
Transformative, instrument-free solution for single cell RNA sequencing updated with improved sensitivity, faster workflow
Parse Biosciences, a leading provider of accessible and scalable single cell sequencing...
The research demonstrates a breakthrough in applying quantum-enhanced generative AI to drug discovery using today’s quantum devices.
Zapata Computing, Inc., the Industrial Generative AI company,...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, and German independent research institute BioMed X,...
Ardigen, a world-leading AI Contract Research Organization (AI CRO) at the forefront of the AI transformation in the biotech and pharmaceutical sectors, is thrilled...
Saama announced the appointment of Bhaskar Sambasivan as Chief Executive Officer. Sambasivan succeeds Vivek Sharma, who is stepping down from his role for personal...
Bioptimus will connect the different scales of biology with generative AI; from molecules to cells, tissues and whole organisms, to fuel scientific breakthroughs and...
AstraZeneca and Daiichi Sankyo’s Biologics License Application (BLA) for datopotamab deruxtecan (Dato-DXd) has been accepted in the US for the treatment of adult patients...
Advances include faster and more robust protein structure prediction; higher-quality models of protein/protein interactions; large-scale screening and improved de novo protein design for therapeutics
OpenFold,...